The Cardiogenomics Clinic uses a patient’s genetic history to help develop a personalized treatment plan based on their genetic results.

For those who had COVID-19, lingering heart problems can complicate their recovery. UAB experts address common concerns that people have with their heart health after COVID-19.

A detailed mechanistic study unravels how the bacterial endotoxin LPS prevents or promotes allergic disease.

Although unproven, this novel sickle cell therapy serves as a potential cure. More measures need to be taken to determine long-term function and organ improvement.

Research in animal models shows better formation of the fistulas, which are a lifeline for kidney failure patients as the connection site to dialysis machines.

The study concluded that participants were hesitant to receive the COVID-19 vaccine due to mistrust, fear and lack of information.

The infusion therapy can help shrink tumors that are otherwise inoperable.

Many Americans are catching up on missed holiday plans, but should you go ahead and receive your booster shot to ensure the safety of yourself and others?

UAB’s Julie Kanter, M.D., says statewide surveillance programs for sickle cell disease can help facilitate progress to improve outcomes.

Live HealthSmart’s goal is to improve Alabama’s national health ranking by 2030.

The effort led by UAB is projected to receive $17 million from NIH to support up to four years of patient follow-up.

The NIH grant creates Multiple Chronic Disease Centers around the nation to target chronic disease in minority populations.

Lupus, an autoimmune disease that can attack any part of the body, can be confounding because patients often respond differently to the same treatment, and they vary widely in the severity of their symptoms.

Record $95 million Heersink lead gift to advance strategic growth and biomedical innovation.

This finding upends the long-held paradigm that priming during lung infections takes place only in the draining lymph nodes, and it will be key to developing more efficient vaccinations and therapies for respiratory challenges.

This award recognizes UAB Hospital’s commitment to meeting standards of excellence in recruitment and retention, education, training and mentoring, research and evidence-based practice, patient outcomes, leadership and organizational ethics, and creation of a healthy work environment.

Monoclonal antibody infusion is effective, but UAB doctors say getting the COVID-19 vaccine is the best way to prevent someone from being hospitalized because of COVID-19.

A Bcl-2 inhibitor that has FDA approval for treatment of several leukemias reversed lung fibrosis in a bleomycin mouse model.

This research suggests that a path to treat currently untreatable cases of cystic fibrosis is clearly achievable.

Many Americans say they want to “make sure the shot is safe” before getting vaccinated. That data is already in, and it is overwhelming.